Metaplastic breast carcinoma needs to be distinguished to the frequently noticed higher-grade metaplastic carcinoma and the rare kinds of metaplastic carcinoma with uncertain malignant prospective (fibromatous-like and adenosquamous carcinoma). Normally, metaplastic breast carcinomas are malignancies with triple-negative immune phenotype, but their